Lilly’s Kisunla Postmarketing Studies Include Maintenance Dosing, But No Safety Trial

 
• By Sue Sutter
Alzheimer's patient
Lilly will assess maintenance dosing with Kisunla. • Source: Shutterstock

More from Approvals

More from Product Reviews